Emerging therapies for hemophilia: A new era of care and the role of the interdisciplinary team

Michelle Witkop, Susan Cutter, Joann Deutsche, Maria Santaella, Robin Chapman, Jennifer Lafranco, Angela Lambing

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The introduction of new hemophilia management therapies, targeting extended half-lives through bioengineering, ushers in an era of potential promise and increasing complexity, more so for those with hemophilia B than hemophilia A. Questions arise for patients, caregivers, and hemophilia treatment center (HTC) staff about how to assess and incorporate novel therapies and how to determine whether new therapies offer a distinct advantage over established treatment routines. Nurses and other interdisciplinary HTC staff are well positioned to assess, educate, and support patients and families in navigating this rapidly changing landscape. To support these challenging efforts, this review offers a perspective on issues affecting therapeutic transitions and provides tools to foster ongoing adherence.

Original languageEnglish (US)
Pages (from-to)790-802
Number of pages13
JournalSeminars in Thrombosis and Hemostasis
Volume40
Issue number7
DOIs
StatePublished - Oct 1 2014

Fingerprint

Hemophilia A
Therapeutics
Hemophilia B
Bioengineering
Caregivers
Nurses

Keywords

  • adherence
  • cultural
  • hemophilia
  • psychosocial
  • therapy transition

ASJC Scopus subject areas

  • Hematology
  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

Witkop, M., Cutter, S., Deutsche, J., Santaella, M., Chapman, R., Lafranco, J., & Lambing, A. (2014). Emerging therapies for hemophilia: A new era of care and the role of the interdisciplinary team. Seminars in Thrombosis and Hemostasis, 40(7), 790-802. https://doi.org/10.1055/s-0034-1384636

Emerging therapies for hemophilia : A new era of care and the role of the interdisciplinary team. / Witkop, Michelle; Cutter, Susan; Deutsche, Joann; Santaella, Maria; Chapman, Robin; Lafranco, Jennifer; Lambing, Angela.

In: Seminars in Thrombosis and Hemostasis, Vol. 40, No. 7, 01.10.2014, p. 790-802.

Research output: Contribution to journalArticle

Witkop, M, Cutter, S, Deutsche, J, Santaella, M, Chapman, R, Lafranco, J & Lambing, A 2014, 'Emerging therapies for hemophilia: A new era of care and the role of the interdisciplinary team', Seminars in Thrombosis and Hemostasis, vol. 40, no. 7, pp. 790-802. https://doi.org/10.1055/s-0034-1384636
Witkop, Michelle ; Cutter, Susan ; Deutsche, Joann ; Santaella, Maria ; Chapman, Robin ; Lafranco, Jennifer ; Lambing, Angela. / Emerging therapies for hemophilia : A new era of care and the role of the interdisciplinary team. In: Seminars in Thrombosis and Hemostasis. 2014 ; Vol. 40, No. 7. pp. 790-802.
@article{f42fa864c3cc42cab5473ac4e5964be5,
title = "Emerging therapies for hemophilia: A new era of care and the role of the interdisciplinary team",
abstract = "The introduction of new hemophilia management therapies, targeting extended half-lives through bioengineering, ushers in an era of potential promise and increasing complexity, more so for those with hemophilia B than hemophilia A. Questions arise for patients, caregivers, and hemophilia treatment center (HTC) staff about how to assess and incorporate novel therapies and how to determine whether new therapies offer a distinct advantage over established treatment routines. Nurses and other interdisciplinary HTC staff are well positioned to assess, educate, and support patients and families in navigating this rapidly changing landscape. To support these challenging efforts, this review offers a perspective on issues affecting therapeutic transitions and provides tools to foster ongoing adherence.",
keywords = "adherence, cultural, hemophilia, psychosocial, therapy transition",
author = "Michelle Witkop and Susan Cutter and Joann Deutsche and Maria Santaella and Robin Chapman and Jennifer Lafranco and Angela Lambing",
year = "2014",
month = "10",
day = "1",
doi = "10.1055/s-0034-1384636",
language = "English (US)",
volume = "40",
pages = "790--802",
journal = "Seminars in Thrombosis and Hemostasis",
issn = "0094-6176",
publisher = "Thieme Medical Publishers",
number = "7",

}

TY - JOUR

T1 - Emerging therapies for hemophilia

T2 - A new era of care and the role of the interdisciplinary team

AU - Witkop, Michelle

AU - Cutter, Susan

AU - Deutsche, Joann

AU - Santaella, Maria

AU - Chapman, Robin

AU - Lafranco, Jennifer

AU - Lambing, Angela

PY - 2014/10/1

Y1 - 2014/10/1

N2 - The introduction of new hemophilia management therapies, targeting extended half-lives through bioengineering, ushers in an era of potential promise and increasing complexity, more so for those with hemophilia B than hemophilia A. Questions arise for patients, caregivers, and hemophilia treatment center (HTC) staff about how to assess and incorporate novel therapies and how to determine whether new therapies offer a distinct advantage over established treatment routines. Nurses and other interdisciplinary HTC staff are well positioned to assess, educate, and support patients and families in navigating this rapidly changing landscape. To support these challenging efforts, this review offers a perspective on issues affecting therapeutic transitions and provides tools to foster ongoing adherence.

AB - The introduction of new hemophilia management therapies, targeting extended half-lives through bioengineering, ushers in an era of potential promise and increasing complexity, more so for those with hemophilia B than hemophilia A. Questions arise for patients, caregivers, and hemophilia treatment center (HTC) staff about how to assess and incorporate novel therapies and how to determine whether new therapies offer a distinct advantage over established treatment routines. Nurses and other interdisciplinary HTC staff are well positioned to assess, educate, and support patients and families in navigating this rapidly changing landscape. To support these challenging efforts, this review offers a perspective on issues affecting therapeutic transitions and provides tools to foster ongoing adherence.

KW - adherence

KW - cultural

KW - hemophilia

KW - psychosocial

KW - therapy transition

UR - http://www.scopus.com/inward/record.url?scp=84928541087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928541087&partnerID=8YFLogxK

U2 - 10.1055/s-0034-1384636

DO - 10.1055/s-0034-1384636

M3 - Article

C2 - 25144753

AN - SCOPUS:84928541087

VL - 40

SP - 790

EP - 802

JO - Seminars in Thrombosis and Hemostasis

JF - Seminars in Thrombosis and Hemostasis

SN - 0094-6176

IS - 7

ER -